<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="lenz" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">lenz</book-part-id>
      <title-group>
        <title>Lenz Microphthalmia Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ng</surname>
            <given-names>David</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>davidng@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>4</day>
          <month>6</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>2</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="revised">
          <day>29</day>
          <month>7</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="legius" document-type="chapter">Legius Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lns" document-type="chapter">Lesch-Nyhan Syndrome</related-object>
      <abstract id="lenz.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Lenz microphthalmia syndrome (LMS) is characterized by unilateral or bilateral microphthalmia and/or clinical anophthalmia with malformations of the ears, teeth, fingers, skeleton, and/or genitourinary system. Microphthalmia is often accompanied by microcornea and glaucoma. Coloboma is present in approximately 60% of microphthalmic eyes with severity ranging from isolated iris coloboma to coloboma of the ciliary body, choroid, and optic disk. Ears may be low set, anteverted, posteriorly rotated, simple, cup shaped, or abnormally modeled. Hearing loss has been observed. Dental findings include irregularly shaped, missing, or widely spaced teeth. Duplicated thumbs, syndactyly, clinodactyly, camptodactyly, and microcephaly are common, as are narrow/sloping shoulders, underdeveloped clavicles, kyphoscoliosis, exaggerated lumbar lordosis, long cylindric thorax, and webbed neck. Genitourinary anomalies include hypospadias, cryptorchidism, renal hypoplasia/aplasia, and hydroureter. Approximately 60% of affected males have mild-to-severe intellectual disability or developmental delay.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of Lenz microphthalmia syndrome is based on clinical findings. Mild simple microphthalmia can be identified by measuring the axial length of the globe with A-scan ultrasonography. <italic toggle="yes">NAA10</italic> (MCOPS1 locus) and <italic toggle="yes">BCOR</italic> (MCOPS2 locus) are the only genes known to be associated with Lenz microphthalmia syndrome (LMS).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> For clinical anophthalmos or extreme microphthalmos: regular evaluation by an ocularist for placement of serial enlarging orbital expanders, physical and occupational therapy, special education, and referral to services for the blind. For hearing loss and sleep disorders: treatment dependent on the specific defect and similar to that used in the general population. Institute regular dental examinations and cleaning should be instituted, especially when cognitive developmental delay is present; dental treatment as for the general population.</p>
          <p><italic toggle="yes">Surveillance</italic>: Annual ophthalmologic examination for those with residual vision, monitoring of renal function, developmental assessments, and lifelong case management to help affected individuals gain access to social services and assistive devices for the blind.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Lenz microphthalmia syndrome is inherited in an X-linked manner. The risk to sibs depends on the carrier status of the mother. If the mother is a carrier, the chance of transmitting the pathogenic variant is 50% in each pregnancy: males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers. The majority of males with Lenz microphthalmia syndrome do not reproduce. Carrier testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible for families in which the pathogenic variant has been identified in an affected family member. Prenatal ultrasound examination at 18 weeks' gestation can be offered for pregnancies at increased risk to evaluate fetal renal development.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="lenz.Diagnosis">
        <title>Diagnosis</title>
        <sec id="lenz.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Lenz microphthalmia syndrome (LMS) should be suspected in males with a combination of the following clinical findings:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Ocular malformation.</bold> Unilateral or bilateral microphthalmia and/or anophthalmia that may be symmetric or asymmetric:</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Anophthalmia</bold> refers to the histologic diagnosis of complete absence of the globe in the presence of ocular adnexae (eyelids, conjunctiva, and lacrimal apparatus). CT or MRI scan of the orbit shows absence of ocular tissue, optic nerve, and extraocular muscles. Note: The term "clinical anophthalmia" should be used for severe microphthalmia when the globe is not detectable on physical examination.</p>
                </list-item>
                <list-item>
                  <p><bold>"Simple microphthalmia" or "pure microphthalmia"</bold> describes a globe that is reduced in total axial length (TAL), has all structural elements intact, and retains some vision. Mild simple microphthalmia can be identified by measuring the axial length of the globe with A-scan ultrasonography. Total axial length of the neonatal eye is normally near 17 mm; an age-adjusted total axial length below the fifth centile defines microphthalmia. The mean total axial length of the adult eye is 23.8 mm; a total axial length of less than 18.5 mm defines microphthalmia.</p>
                </list-item>
                <list-item>
                  <p><bold>Coloboma</bold> is present in approximately 60% of microphthalmic eyes [<xref ref-type="bibr" rid="lenz.REF.ng.2002.308">Ng et al 2002</xref>], with severity ranging from isolated iris coloboma to coloboma of the ciliary body, choroid, and optic disk.</p>
                </list-item>
                <list-item>
                  <p><bold>Congenital cystic eye</bold> has not been observed in LMS.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Extraocular malformations</bold> that vary within and among families:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Hypospadias, cryptorchidism, renal aplasia/hypoplasia, hydroureter (77% of individuals)</p>
                </list-item>
                <list-item>
                  <p>Simple, anteverted, abnormally modeled ears (63%)</p>
                </list-item>
                <list-item>
                  <p>Abnormal shape of incisors, irregularly spaced teeth (48%)</p>
                </list-item>
                <list-item>
                  <p>Duplicated thumbs, syndactyly, clinodactyly, camptodactyly (44%)</p>
                </list-item>
                <list-item>
                  <p>Microcephaly (37%)</p>
                </list-item>
                <list-item>
                  <p>Narrow/sloping shoulders, underdeveloped clavicles, kyphoscoliosis, exaggerated lumbar lordosis, long cylindrical thorax, webbed neck (26%)</p>
                </list-item>
                <list-item>
                  <p>Cleft lip/palate (7%)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Intellectual disability</bold> ranging from mild to severe (63%)</p>
            </list-item>
            <list-item>
              <p><bold>Family history</bold> consistent with X-linked recessive inheritance</p>
            </list-item>
          </list>
        </sec>
        <sec id="lenz.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of LMS is established in a proband with identification of a pathogenic variant in one of two known genes, <italic toggle="yes">BCOR</italic> or <italic toggle="yes">NAA10</italic> (see <xref ref-type="table" rid="lenz.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          <p><bold>One genetic testing strategy</bold> is serial single-gene molecular genetic testing of <italic toggle="yes">BCOR</italic> and <italic toggle="yes">NAA10</italic>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">BCOR</italic>.</bold> p.Pro85Leu, the only <italic toggle="yes">BCOR</italic> pathogenic variant found in individuals with LMS to date, can be identified by targeted analysis for pathogenic variants [<xref ref-type="bibr" rid="lenz.REF.ng.2004.411">Ng et al 2004</xref>, <xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al 2009</xref>, <xref ref-type="bibr" rid="lenz.REF.suzumori.2013.1545">Suzumori et al 2013</xref>]. If targeted analysis does not identify a pathogenic variant, sequence analysis can be performed, followed by deletion/duplication analysis if no pathogenic variant is identified.</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">NAA10.</italic></bold> c.471+2T&#x0003e;A is to date the only <italic toggle="yes">NAA10</italic> pathogenic variant (found in 1 family with LMS). Sequencing of <italic toggle="yes">NAA10</italic> should be performed first. If no pathogenic variant is identified, deletion/duplication analysis for partial or complete <italic toggle="yes">NAA10</italic> deletion should be considered.</p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">BCOR, NAA10</italic> and other genes of interest (see <xref ref-type="sec" rid="lenz.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of LMS. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="lenz.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Lenz Microphthalmia Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_2">Test Method</th>
                  <th id="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3" id="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Affected Males</th>
                  <th headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3" id="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Carrier Females</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">BCOR</italic>
                  </td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted sequence analysis for c.254C&#x0003e;T&#x000a0;<sup>2,&#x000a0;3</sup></td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">NAA10</italic>
                  </td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_lenz.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="lenz.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="lenz" object-id="lenz.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="lenz.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="lenz.TF.1.2">
                <label>2. </label>
                <p>Pathogenic variants included in a panel may vary by laboratory.</p>
              </fn>
              <fn id="lenz.TF.1.3">
                <label>3. </label>
                <p>A pathogenic missense variant, c.254C&#x0003e;T, resulting in a change of amino acid at position 85 from proline to leucine (p.Pro85Leu) in <italic toggle="yes">BCOR</italic>, was found in affected males of the family used to map the MOCPS2 locus [<xref ref-type="bibr" rid="lenz.REF.ng.2002.308">Ng et al 2002</xref>, <xref ref-type="bibr" rid="lenz.REF.ng.2004.411">Ng et al 2004</xref>], in a white male reported by <xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al [2009]</xref>, and in two Japanese families reported by <xref ref-type="bibr" rid="lenz.REF.suzumori.2013.1545">Suzumori et al [2013]</xref>. The low frequency of <italic toggle="yes">BCOR</italic> pathogenic variants does not allow determination of the variant detection frequency.</p>
              </fn>
              <fn id="lenz.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="lenz.TF.1.5">
                <label>5. </label>
                <p>c.471+2T&#x0003e;A, a splice variant that may lead to aberrant splicing of exons 7 and 8 of <italic toggle="yes">NAA10</italic>, has been reported in three affected males with the LMS phenotype that mapped to the MCOPS1 locus [<xref ref-type="bibr" rid="lenz.REF.forrester.2001.92">Forrester et al 2001</xref>, <xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>]. The frequency of <italic toggle="yes">NAA10</italic>-associated LMS is unknown.</p>
              </fn>
              <fn id="lenz.TF.1.6">
                <label>6. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="lenz.TF.1.7">
                <label>7. </label>
                <p>An Irish family with microphthalmia/anophthalmia, ankyloblepharon and intellectual disability (MCOPS4) was previously mapped to Xq27-q28 [<xref ref-type="bibr" rid="lenz.REF.graham.1991.43">Graham et al 1991</xref>]. No causative gene has been identified (one individual from this family was screened for an <italic toggle="yes">NAA10</italic> pathogenic variant and none was found [<xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="lenz.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="lenz.Clinical_Description">
          <title>Clinical Description</title>
          <p>The phenotype of Lenz microphthalmia syndrome, microphthalmia with developmental delay and skeletal and urogenital anomalies associated with <italic toggle="yes">NAA10</italic> (MCOPS1 locus) cannot easily be distinguished from the LMS phenotype caused by the pathogenic missense variant p.Pro85Leu in <italic toggle="yes">BCOR</italic> (MCOPS2 locus). It is difficult to make phenotypic comparisons between MCOPS1 and MCOPS2 as only one family has been identified with an <italic toggle="yes">NAA10</italic> pathogenic variant. Affected males with <italic toggle="yes">NAA10</italic> splice variant c.471+2T&#x0003e;A exhibited a greater degree of cognitive impairment, gastrointestinal symptoms, two-three toe cutaneous syndactyly with short terminal phalanges in the hand, and development of scoliosis and neuropathic muscle degeneration over time. These findings have not been reported in males with LMS caused by the <italic toggle="yes">BCOR</italic> variant p.Pro85Leu.</p>
          <p>Lenz microphthalmia syndrome has a wide spectrum of ocular and extraocular abnormalities.</p>
          <p><bold>Eyes.</bold> The eyes may be asymmetrically affected. One globe can be of normal size while the other is microphthalmic. Severity can range from mild microphthalmia with retained vision to severe microphthalmia or clinical anophthalmia with blindness. Microphthalmia is often accompanied by microcornea and reduction in the size of the anterior segment of the eye, which predispose to the development of glaucoma.</p>
          <p>Since mild microphthalmia may not be obvious on clinical examination, individuals with LMS with retained vision may not be identified until the first ophthalmologic examination when high hyperopia (+7 to +11 diopters) secondary to a foreshortened posterior segment of the globe is diagnosed.</p>
          <p>Cataracts may be present.</p>
          <p>Nystagmus may be present secondary to impaired vision.</p>
          <p>Absence or diminished size of the globe may cause secondary underdevelopment of the bony orbits, shortened palpebral fissures, and fusion of the eyelid margins (ankyloblepharon).</p>
          <p><bold>Craniofacial.</bold> The occurrence of congenital microcephaly is variable. Affected individuals may be normocephalic or dolichocephalic.</p>
          <p>Ears may be low set, anteverted, posteriorly rotated, simple, cup shaped, or abnormally modeled. Preauricular tags may be present.</p>
          <p>Hearing loss has been observed.</p>
          <p>Cleft lip/palate or high arched palate is present in approximately 12/30 of individuals [<xref ref-type="bibr" rid="lenz.REF.ng.2002.308">Ng et al 2002</xref>].</p>
          <p>Dental development may be delayed. Nonspecific dental findings include irregularly shaped, missing, or widely spaced teeth.</p>
          <p><bold>Genitourinary.</bold> Urogenital anomalies are the most frequent associated findings, reported in approximately 23/30 of individuals [<xref ref-type="bibr" rid="lenz.REF.ng.2002.308">Ng et al 2002</xref>]. These include hypospadias, cryptorchidism, renal hypoplasia/aplasia, and hydroureter.</p>
          <p><bold>Limbs.</bold> Hand findings include duplicated and/or proximally placed thumbs, cutaneous syndactyly, clinodactyly, and camptodactyly.</p>
          <p><bold>Skeletal.</bold> Long cylindric thorax with sloping, narrow shoulders, underdeveloped clavicles, or thinning of the lateral third of the clavicles on x-ray as well as kyphoscoliosis and exaggerated lumbar lordosis have been seen in some families.</p>
          <p><bold>Cognitive/neurologic.</bold> Cognitive impairment varies within and among families. Approximately 22/35 of affected males have mild-to-severe intellectual disability or developmental delay [<xref ref-type="bibr" rid="lenz.REF.ng.2002.308">Ng et al 2002</xref>].</p>
          <p>Motor development may be delayed.</p>
          <p>Seizures, behavioral disturbance, and self-mutilation may manifest in males with severe intellectual disability. Sleep-wake cycles can be disturbed because of lack of normal diurnal variation.</p>
          <p>Cranial MRI often reveals absent or hypoplastic optic nerves and optic chiasm. In addition, hypoplasia of the corpus callosum and cingulate gyrus has been noted. The latter is often clinically silent.</p>
          <p><bold>Heterozygotes.</bold> Features of LMS and OFCD have not been reported in female carriers of the <italic toggle="yes">BCOR</italic> variant p.Pro85Leu. In one family, two-three toe cutaneous syndactyly and short terminal phalanges in the hand were reported in female carriers of <italic toggle="yes">NAA10</italic> variant c.471+2T&#x0003e;A [<xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>].</p>
        </sec>
        <sec id="lenz.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations are known.</p>
          <p>Males reported with LMS and a <italic toggle="yes">BCOR</italic> pathogenic variant had the p.Pro85Leu pathogenic variant; however, one reported male exhibited radioulnar synostosis, which occurs in 7/35 of those with oculofaciocardiodental (OFCD) syndrome (see <xref ref-type="sec" rid="lenz.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>). Thus, the presence of radioulnar synostosis in a male with LMS may indicate the presence of a <italic toggle="yes">BCOR</italic> pathogenic variant [<xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al 2009</xref>].</p>
        </sec>
        <sec id="lenz.Penetrance">
          <title>Penetrance</title>
          <p>An insufficient number of cases of Lenz microphthalmia exist to comment on penetrance.</p>
        </sec>
        <sec id="lenz.Nomenclature">
          <title>Nomenclature</title>
          <p>Lenz microphthalmia syndrome (LMS) has been referred to as Lenz dysplasia, Lenz dysmorphogenetic syndrome, and microphthalmia with associated anomalies. The two loci were formerly designated MAA and MAA2 (or ANOP2).</p>
          <p>The locus designations MAA (now associated with syndromic microphthalmia 1 [MCOPS1, <italic toggle="yes">NAA10</italic>]), and MAA2 (now associated with syndromic microphthalmia 2 [MCOPS2, <italic toggle="yes">BCOR</italic>]) were used to highlight the genetic heterogeneity of LMS and the associated extraocular developmental anomalies and intellectual disability that co-occur with the microphthalmia in affected males.</p>
          <p>MCOPS2 has since been redesignated oculofaciocardiodental syndrome (OFCD) due to the higher prevalence of <italic toggle="yes">BCOR</italic> loss-of-function variants with OFCD. However, the <italic toggle="yes">BCOR</italic> p.Pro85Leu pathogenic missense variant remains a known cause of LMS.</p>
          <p>Although the consensus inheritance pattern is X-linked recessive, the term Lenz microphthalmia is used by clinicians for simplex cases (i.e., single occurrence in a family) with a Lenz-like phenotype.</p>
        </sec>
        <sec id="lenz.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence in ethnic groups is unknown. Most reported cases are of European descent. <italic toggle="yes">BCOR</italic> p.Pro85Leu appears to be pan ethnic and has been reported in an African American family [<xref ref-type="bibr" rid="lenz.REF.ng.2002.308">Ng et al 2002</xref>], a European family [<xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al 2009</xref>], and two Japanese families [<xref ref-type="bibr" rid="lenz.REF.suzumori.2013.1545">Suzumori et al 2013</xref>]. <italic toggle="yes">NAA10</italic> c.471+2T&#x0003e;A has been found in one family of mixed European descent [<xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>].</p>
        </sec>
      </sec>
      <sec id="lenz.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Oculofaciocardiodental (OFCD) syndrome</bold> is also associated with pathogenic variants in <italic toggle="yes">BCOR</italic> [<xref ref-type="bibr" rid="lenz.REF.ng.2004.411">Ng et al 2004</xref>, <xref ref-type="bibr" rid="lenz.REF.horn.2005.563">Horn et al 2005</xref>, <xref ref-type="bibr" rid="lenz.REF.oberoi.2005.275">Oberoi et al 2005</xref>].</p>
        <p>OFCD syndrome is inherited in an X-linked pattern with male lethality.</p>
        <p>Females with OFCD syndrome may have congenital cataracts as the sole ocular manifestation or unilateral/bilateral microphthalmia with congenital cataracts. Microphthalmia is less severe in OFCD syndrome than in LMS.</p>
        <p>Extraocular features include long narrow face, broad nasal tip with separated nasal cartilage, cleft palate, submucous cleft palate, cardiac anomalies (ventricular septal defect, atrial septal defect, floppy mitral valve) and dental anomalies (retained deciduous teeth, canine radiculomegaly, root dilacerations, oligodontia).</p>
        <p>Females with OFCD syndrome have normal intelligence, in contrast to males with LMS, who often have developmental delay/intellectual disability, microcephaly, and structural CNS abnormalities.</p>
        <p>The majority of individuals with OFCD syndrome analyzed thus far have detectable <italic toggle="yes">BCOR</italic> pathogenic variants [<xref ref-type="bibr" rid="lenz.REF.ng.2004.411">Ng et al 2004</xref>, <xref ref-type="bibr" rid="lenz.REF.horn.2005.563">Horn et al 2005</xref>, <xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al 2009</xref>]. Two <italic toggle="yes">BCOR</italic> deletions that encompass several exons have been observed and can be detected by targeted array CGH.</p>
        <p>Individuals with OFCD syndrome have pathogenic variants that are predicted to prematurely truncate the BCOR protein. In hemizygous males, truncating variants are hypothesized to lead to a complete loss of <italic toggle="yes">BCOR</italic> function and are presumed to be lethal. Truncating <italic toggle="yes">BCOR</italic> variants in females lead to haploinsufficiency and a milder phenotype. All families with OFCD syndrome have unique pathogenic variants.</p>
        <p>Based on the known cases of OFCD syndrome scanned for <italic toggle="yes">BCOR</italic> pathogenic variants, penetrance is complete.</p>
        <p>Three females with features of OFCD syndrome but with notable absence of dental radiculomegaly did not have identifiable <italic toggle="yes">BCOR</italic> pathogenic variants [<xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al 2009</xref>].</p>
        <p><bold>Ogden syndrome</bold> is also associated with <italic toggle="yes">NAA10</italic> pathogenic missense variants (p.Ser37Pro and p.Arg116Trp) [<xref ref-type="bibr" rid="lenz.REF.rope.2011.28">Rope et al 2011</xref>]. Ogden syndrome is an X-linked disorder with male lethality during infancy. Affected males have multiple dysmorphic features (prominent eyes, downslanting palpebral fissures, large ears, and microretrognathia), congenital heart defects, delayed closure of fontanelles, scoliosis, cutis laxa, neurologic abnormalities (seizures and hypotonia) and cardiac arrhythmia. Female carriers of these pathogenic missense variants are asymptomatic.</p>
      </sec>
      <sec id="lenz.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <related-object link-type="booklink" source-id="gene" document-id="anophthalmia-ov" document-type="chapter">Anophthalmia/Microphthalmia Overview</related-object>.</p>
        <p>A Hispanic family with isolated X-linked colobomatous microphthalmia has been reported [<xref ref-type="bibr" rid="lenz.REF.lehman.2001.114">Lehman et al 2001</xref>] and an American family of European descent with syndromic X-linked colobomatous microphthalmia has been identified with a frameshift variant in <italic toggle="yes">HMGB3</italic> [<xref ref-type="bibr" rid="lenz.REF.scott.2014.1215">Scott et al 2014</xref>].</p>
      </sec>
      <sec id="lenz.Management">
        <title>Management</title>
        <sec id="lenz.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Lenz microphthalmia syndrome (LMS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical examination for the presence of anomalies associated with the disorder</p>
            </list-item>
            <list-item>
              <p>Cranial MRI to estimate the size of the globes for prognosis regarding potential visual function and to detect concurrent CNS malformations such as hypoplastic corpus callosum and cingulate gyrus</p>
            </list-item>
            <list-item>
              <p>Visual evoked response testing and ophthalmologic examination to help determine visual acuity and/or the potential for vision</p>
            </list-item>
            <list-item>
              <p>Consideration of echocardiogram if physical exam detects findings suggestive of a congenital cardiac malformation. (A single case report from Japan described an infant with a molecularly confirmed LMS (BCOR p.Pro85Leu) dying of an unspecified cardiac defect at age six months [<xref ref-type="bibr" rid="lenz.REF.suzumori.2013.1545">Suzumori et al 2013</xref>].)</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination to evaluate for renal aplasia, hypoplasia, and hydroureter</p>
            </list-item>
            <list-item>
              <p>Consideration of hearing evaluation during infancy if:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Head and neck examination reveals malformations of the auricle or ear canal, presence of skin tags or dimples around the ear, presence of cleft lip or palate, asymmetric facies, and microcephaly</p>
                </list-item>
                <list-item>
                  <p>The parents have concerns that the child cannot hear (e.g., infant does not startle to loud noises, awaken to sound). The type of examination should be adjusted for the individual's cognitive level to allow for cooperation and maximize the chance of an informative test (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Consideration of sleep evaluation if parents report excessive daytime somnolence, altered sleep-wake cycles, difficulty awakening the child or getting the child to fall asleep, apnea, loud snoring, and/or difficulty breathing while asleep</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="lenz.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Individuals with anophthalmos or extreme microphthalmos benefit from regular evaluations by an ocularist for placement of serial enlarging orbital expanders to prevent deformation of facial structures and to encourage normal development of eye lashes and lid margins.</p>
          <p>Early intervention with physical therapy and occupational therapy helps to address disturbances of the sleep-wake cycle caused by lack of light perception and problems of delayed gross motor development often observed in children with visual impairment.</p>
          <p>Early intervention with special education maximizes cognitive development.</p>
          <p>Referral to services for the visually impaired is recommended.</p>
          <p>Treatment for hearing loss and sleep disorders is dependent on the specific defect and similar to the general population.</p>
          <p>Referral to a sleep disorder specialist may be necessary depending on the individual's history and presentation to determine the appropriate tests.</p>
          <p>Dental examinations and cleaning should be instituted to monitor dental hygiene, especially when the affected individual has cognitive developmental delay. Missing and irregularly shaped teeth and wide spacing of teeth are common. Treatment is the same as for the general population in restoring masticatory function.</p>
        </sec>
        <sec id="lenz.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>No special preventative care is recommended. Follow-up care is personalized based on the physical impairments found in the individual.</p>
        </sec>
        <sec id="lenz.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual ophthalmologic examination for those with residual vision given the predisposition to glaucoma and high hyperopia from foreshortening of the globe</p>
            </list-item>
            <list-item>
              <p>Monitoring of renal function (BUN, creatinine, and urine analysis) in those with known renal/ureteral anomalies</p>
            </list-item>
            <list-item>
              <p>Developmental assessments performed with each well-child visit as recommended by the American Academy of Pediatrics. More frequent and specialized assessments are tailored to each child if development is not on track.</p>
            </list-item>
            <list-item>
              <p>Lifelong case management to help affected individuals gain access to social services and assistive devices for the blind</p>
            </list-item>
          </list>
        </sec>
        <sec id="lenz.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>In those with residual vision, dilating drops and medications that may dilate the pupils (i.e., antihistamines, decongestants, tricyclic antidepressants) should be used in consultation with an ophthalmologist because of the narrow anterior chamber and risk for angle closure glaucoma.</p>
        </sec>
        <sec id="lenz.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="lenz.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="lenz.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="lenz.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="lenz.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Lenz microphthalmia syndrome is inherited in an X-linked manner.</p>
        </sec>
        <sec id="lenz.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will neither have the disease nor be a carrier of a <italic toggle="yes">BCOR</italic> or <italic toggle="yes">NAA10</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected male, the mother of an affected male is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>If only one male in the family is affected, the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant, in which case the mother is not a carrier. The frequency of <italic toggle="yes">de novo</italic> pathogenic variants is not known. To date, all published cases have been inherited.</p>
            </list-item>
            <list-item>
              <p>To date there are no reports of germline mosaicism in a mother.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to sibs depends on the carrier status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has a <italic toggle="yes">BCOR</italic> or <italic toggle="yes">NAA10</italic> pathogenic variant, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers.</p>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the pathogenic variant cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The majority of males with Lenz microphthalmia syndrome do not have children, possibly as a result of infertility or decreased reproductive fitness secondary to cognitive impairment. Males who are capable of reproducing pass the pathogenic variant to all of their daughters and none of their sons.</p>
          <p><bold>Other family members.</bold> The proband's maternal aunts may be at risk of being carriers and the aunts&#x02019; offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="lenz.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk females requires prior identification of the <italic toggle="yes">BCOR</italic> or <italic toggle="yes">NAA10</italic> pathogenic variant in the family.</p>
          <p>Note: Carriers are heterozygous for this X-linked disorder and are generally asymptomatic (see <xref ref-type="sec" rid="lenz.Clinical_Description">Clinical Description</xref>, <bold>Heterozygotes</bold>).</p>
        </sec>
        <sec id="lenz.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for discussion of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="lenz.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">BCOR</italic> or <italic toggle="yes">NAA10</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for Lenz microphthalmia syndrome are possible.</p>
          <p><bold>Ultrasound examination.</bold> Prenatal ultrasound examination at 18 weeks' gestation can be offered for pregnancies at increased risk to evaluate fetal renal development. No data exist regarding the effectiveness of screening for other malformations in fetuses at risk for LMS, although prenatal ultrasound at 15 weeks&#x02019; gestation found evidence of unopened palpebral fissures suggestive of underdeveloped eyes [<xref ref-type="bibr" rid="lenz.REF.suzumori.2013.1545">Suzumori et al 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="lenz.Resources">
        <title>Resources</title>
      </sec>
      <sec id="lenz.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">BCOR</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">BCOR</italic> extends over approximately 55 kb and includes 15 exons. The reference cDNA for <italic toggle="yes">BCOR</italic> isoform 1 is 6182 bp (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_017745.5">NM_017745.5</ext-link>). The open reading frame is 5163 bp. <italic toggle="yes">BCOR</italic> isoform 2 is 3676 bp. <italic toggle="yes">BCOR</italic> long isoform, alternatively spliced is 5810 bp (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/38018405">AY316592.1</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="lenz" object-id="lenz.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Four families have been reported with males affected with Lenz microphthalmia syndrome (LMS) due to (MCOPS2) c.254C&#x0003e;T (p.Pro85Leu) [<xref ref-type="bibr" rid="lenz.REF.ng.2004.411">Ng et al 2004</xref>, <xref ref-type="bibr" rid="lenz.REF.hilton.2009.1325">Hilton et al 2009</xref>, <xref ref-type="bibr" rid="lenz.REF.suzumori.2013.1545">Suzumori et al 2013</xref>].</p>
        <table-wrap id="lenz.T.bcor_pathogenic_variants_discusse" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">BCOR</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_lenz.T.bcor_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_lenz.T.bcor_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_lenz.T.bcor_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_lenz.T.bcor_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.254C&#x0003e;T</td>
                <td headers="hd_h_lenz.T.bcor_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro85Leu</td>
                <td headers="hd_h_lenz.T.bcor_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_017745.5">NM_017745.5</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_060215.4">NP_060215.4</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">BCOR</italic> isoform 1 encodes a protein of 1721amino acids. <italic toggle="yes">BCOR</italic> isoform 2 encodes a protein of 1004 amino acids. <italic toggle="yes">BCOR</italic> long isoform, alternatively spliced encodes a protein of 1755 amino acids.</p>
        <p><bold>Abnormal gene product.</bold> The p.Pro85Leu pathogenic variant is expressed and results in perturbation of ocular and extraocular organ development. Truncated and abnormally spiced variants of <italic toggle="yes">BCOR</italic> have not been detected in individuals with OFCD syndrome and are hypothesized to be eliminated by nonsense-mediated mRNA decay.</p>
        <p>
          <bold>
            <italic toggle="yes">NAA10</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">NAA10</italic> isoform 1 encodes a protein consisting of 235 amino acids. <italic toggle="yes">NAA10</italic> isoform 2 encodes a protein consisting of 220 amino acids and isoform 3 encodes a protein of 229 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="lenz" object-id="lenz.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> The c.471+2T&#x0003e;A pathogenic variant affects the <italic toggle="yes">NAA10</italic> canonical splice donor site of intron 7. Primers amplifying the <italic toggle="yes">NAA10</italic> cDNA of exons 5 through 8 showed the presence of an abnormal exon7-intron7-exon8 fusion product (mutated splice variant 1) and no wild-type cDNA product was present in affected males [<xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>].</p>
        <table-wrap id="lenz.T.naa10_pathogenic_variants_discuss" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">NAA10</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_lenz.T.naa10_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_lenz.T.naa10_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_lenz.T.naa10_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_lenz.T.naa10_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.471+2T&#x0003e;A</td>
                <td headers="hd_h_lenz.T.naa10_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                <td headers="hd_h_lenz.T.naa10_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003491.3">NM_003491.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003482.1">NP_003482.1</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">NAA10</italic> codes for the catalytic subunit of the N-terminal acetyl transferase (hNatA) [<xref ref-type="bibr" rid="lenz.REF.starheim.2009.s3">Starheim et al 2009</xref>, <xref ref-type="bibr" rid="lenz.REF.rope.2011.28">Rope et al 2011</xref>]. N-terminal acetylation (NAT) of proteins is one of the most common protein modifications [<xref ref-type="bibr" rid="lenz.REF.arnesen.2009.s1">Arnesen 2009</xref>]. It is estimated that hNatA has over 8000 human protein substrates [<xref ref-type="bibr" rid="lenz.REF.starheim.2009.s3">Starheim et al 2009</xref>]; hNatA complex is highly conserved from yeast. Knockdown experiments of hNatA affected substrates involved in protein-protein interactions, transcriptional regulation, ribosome assembly, RNA maturation, and protein folding and modification [<xref ref-type="bibr" rid="lenz.REF.starheim.2009.s3">Starheim et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> A lower molecular weight protein compared to wild-type control was present in one affected male suggesting the presence of a truncated NAA10 protein; protein sequencing was not performed. Fibroblasts derived from affected males showed deficient growth compared to normal control. Western blot analysis of fibroblast derived protein from an affected male showed no detectable wild-type NAA10 protein [<xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>]. Results from gene expression profile from three affected males suggested perturbation of the retinoic signaling pathway [<xref ref-type="bibr" rid="lenz.REF.esmailpour.2014.185">Esmailpour et al 2014</xref>].</p>
      </sec>
      <sec id="lenz.References">
        <title>References</title>
        <sec id="lenz.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="lenz.Literature_Cited.reflist0">
            <ref id="lenz.REF.arnesen.2009.s1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arnesen</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Protein N-terminal acetylation: NAT 2007-2008 Symposia.</article-title>
                <source>BMC Proc.</source>
                <year>2009</year>
                <volume>3</volume>
                <supplement>Suppl 6</supplement>
                <fpage>S1</fpage>
                <pub-id pub-id-type="pmid">19660094</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.esmailpour.2014.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Esmailpour</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riazifar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donkervoort</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madaan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoucri</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadwick</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vawter</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>51</volume>
                <fpage>185</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">24431331</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.forrester.2001.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forrester</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovach</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynolds</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Manifestations in four males with and an obligate carrier of the Lenz microphthalmia syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>98</volume>
                <fpage>92</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">11426460</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.graham.1991.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redmond</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevin</surname>
                    <given-names>NC</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>X-linked clinical anophthalmos. Localization of the gene to Xq27-Xq28.</article-title>
                <source>Ophthalmic Paediatr Genet</source>
                <volume>12</volume>
                <fpage>43</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1679229</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.hilton.2009.1325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hilton</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whalen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatsukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torii</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manouvrier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boute</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perveen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Law</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fellmann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debray</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastot-Le-Moal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schinzel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholdi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardakjian</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hay</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenny</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyons</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belmont</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>BCOR analysis in patients with OFCD and Lenz microphthalmia syndromes, mental retardation with ocular anomalies, and cardiac laterality defects.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>17</volume>
                <fpage>1325</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">19367324</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.horn.2005.563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chyrek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000fc;ttgen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinkel</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenke</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schell-Apacik</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinschert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieczorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kaesbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutsche</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>13</volume>
                <fpage>563</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15770227</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.lehman.2001.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lehman</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sponsel</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratton</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson-Pais</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coon</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reveles</surname>
                    <given-names>XT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cody</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leach</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Genetic mapping of a novel X-linked recessive colobomatous microphthalmia.</article-title>
                <source>Am J Med Genet</source>
                <volume>101</volume>
                <fpage>114</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11391653</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.ng.2002.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadley</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tifft</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Genetic heterogeneity of syndromic X-linked recessive microphthalmia-anophthalmia: is Lenz microphthalmia a single disorder?</article-title>
                <source>Am J Med Genet</source>
                <volume>110</volume>
                <fpage>308</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">12116202</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.ng.2004.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corcoran</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perveen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadley</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tifft</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkie</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Smagt</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorlin</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgess</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardwell</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>411</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15004558</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.oberoi.2005.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oberoi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winder</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargervik</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavotinek</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Case reports of oculofaciocardiodental syndrome with unusual dental findings.</article-title>
                <source>Am J Med Genet A</source>
                <volume>136</volume>
                <fpage>275</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15957158</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.rope.2011.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rope</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evjenth</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swensen</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huff</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schank</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fain</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robison</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalley</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>South</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pysher</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorde</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakonarson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillehaug</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yandell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnesen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyon</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <article-title>Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2011</year>
                <volume>89</volume>
                <fpage>28</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">21700266</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.scott.2014.1215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohr</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasch</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittiglio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingersoll</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marosy</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doheny</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromley</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roderick</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chassaing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prabhu</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabs</surname>
                    <given-names>EW</given-names>
                  </name>
                </person-group>
                <article-title>Identification of an HMGB3 frameshift mutation in a family with an X-linked colobomatous microphthalmia syndrome using whole-genome and X-exome sequencing.</article-title>
                <source>JAMA Ophthalmol.</source>
                <year>2014</year>
                <volume>132</volume>
                <fpage>1215</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">24993872</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.starheim.2009.s3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Starheim</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gromyko</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varhaug</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnesen</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Composition and biological significance of the human Nalpha-terminal acetyltransferases.</article-title>
                <source>BMC Proc.</source>
                <year>2009</year>
                <volume>3</volume>
                <supplement>Suppl 6</supplement>
                <fpage>S3</fpage>
                <pub-id pub-id-type="pmid">19660096</pub-id>
              </element-citation>
            </ref>
            <ref id="lenz.REF.suzumori.2013.1545">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suzumori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaname</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muramatsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumagai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naritomi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitoh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugiura-Ogasawara</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Prenatal diagnosis of X-linked recessive Lenz microphthalmia.</article-title>
                <source>J Obstet Gynaecol Res</source>
                <volume>39</volume>
                <fpage>1545</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23815237</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="lenz.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="lenz.Suggested_Reading.reflist0">
            <ref id="lenz.REF.mart_nezgaray.2007.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Garay</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tom&#x000e1;s</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oltra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramser</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molt&#x000f3;</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prieto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutsche</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>A two base pair deletion in the PQBP1 gene is associated with microphthalmia, microcephaly, and mental retardation.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2007</year>
                <volume>15</volume>
                <fpage>29</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">17033686</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="lenz.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="lenz.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>2 October 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 April 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 July 2007 (cd) Revision: clinical testing for <italic toggle="yes">BCOR</italic> mutations no longer available</p>
            </list-item>
            <list-item>
              <p>6 September 2006 (cd) Revision: FISH, mutation scanning, linkage analysis, and X-chromosome inactivation studies no longer clinically available for <italic toggle="yes">BCOR</italic></p>
            </list-item>
            <list-item>
              <p>23 June 2006 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>12 April 2005 (dn) Revision: <italic toggle="yes">BCOR</italic> testing clinically available</p>
            </list-item>
            <list-item>
              <p>13 May 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 February 2004 (dn) Revision: Molecular Genetics</p>
            </list-item>
            <list-item>
              <p>4 June 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 February 2002 (dn) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Lenz Microphthalmia Syndrome&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
